Bi -institutional Safety Analysis of Combining Radiotherapy and Enfortumab Vedotin in Advanced Urothelial Cancer

被引：0
|
作者：
Soni, Y. S. [1 ]
Lock, D. [2 ]
Ballas, L. K. [3 ]
Hwang, L. [2 ]
Cole, S. [4 ]
D'Souza, A. [5 ]
Zhang, T. [4 ]
Garant, A. [1 ]
Yang, D. X. [1 ]
Arafat, W. [4 ]
Desai, N. B. [1 ]
机构：
[1] Univ Texas Southwestern Med Ctr, Dept Radiat Oncol, Dallas, TX USA
[2] LAC USC Med Ctr, Dept Radiat Oncol, Los Angeles, CA USA
[3] Cedars Sinai Med Ctr, Dept Radiat Oncol, Los Angeles, CA USA
[4] Univ Texas Southwestern Med Ctr, Dept Hematol & Oncol, Dallas, TX USA
[5] LAC USC Med Ctr, Dept Hematol & Oncol, Los Angeles, CA USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2024年 / 120卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
222
引用
收藏
页码：S74 / S75
页数：2
相关论文
共 50 条
  • [41] Real-world use, dose intensity, and adherence to enfortumab vedotin in locally advanced or metastatic urothelial cancer
    Mamtani, Ronac
    Tsingas, Konstantinos
    Parikh, Ravi B.
    Elsouda, Dina
    Mucha, Lisa
    Fuldeore, Rupali
    Hubbard, Rebecca A.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2024, 42 (06) : e1 - e4
  • [42] Impact of squamous histology on outcomes with enfortumab vedotin in patients with advanced urothelial carcinoma: Analysis of the UNITE study.
    Jindal, Tanya
    Alhalabi, Omar
    Nguyen, Charles B.
    Bakaloudi, Dimitra Rafailia
    Nizam, Amanda
    Bilen, Mehmet Asim
    Basu, Arnab
    Zakharia, Yousef
    Milowsky, Matthew I.
    Brown, Jason R.
    Kilari, Deepak
    Shah, Sumit
    Emamekhoo, Hamid
    Grivas, Petros
    Hoimes, Christopher J.
    Gupta, Shilpa
    Bellmunt, Joaquim
    Campbell, Matthew T.
    Alva, Ajjai Shivaram
    Koshkin, Vadim S.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 651 - 651
  • [43] ASSOCIATION BETWEEN CUTANEOUS REACTIONS RELATED TO ENFORTUMAB VEDOTIN AND SERUM ALBUMIN LEVELS IN PATIENTS WITH ADVANCED UROTHELIAL CANCER
    Yamamoto, Hayato
    Yoneyama, Fumiya
    Ishii, Noritaka
    Soma, Osamu
    Fujita, Naoki
    Okamoto, Teppei
    Yoneyama, Takahiro
    Hatakeyama, Shingo
    JOURNAL OF UROLOGY, 2024, 211 (05): : E873 - E873
  • [44] EV-103: Enfortumab vedotin plus pembrolizumab and/or chemotherapy for locally advanced or metastatic urothelial cancer.
    Hoimes, Christopher J.
    Rosenberg, Jonathan E.
    Petrylak, Daniel Peter
    Carret, Anne-Sophie
    Melhem-Bertrandt, Amal
    Flaig, Thomas W.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [45] ABC transporter expression to predict therapeutic effect of enfortumab vedotin in urothelial cancer
    Shimoda, Hiroki
    Takada-Owada, Atsuko
    Kijima, Toshiki
    Kokubun, Hidetoshi
    Uematsu, Toshitaka
    Takei, Kohei
    Nakazato, Yoshimasa
    Yashi, Masahiro
    Ishida, Kazuyuki
    Kamai, Takao
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 693 - 693
  • [46] First Evidence of Activity of Enfortumab Vedotin on Brain Metastases in Urothelial Cancer Patients
    Vulsteke, Christof
    De Cocker, Laurens
    de Liano, Alfonso Gomez
    Montesdeoca, Cristina
    De Meulenaere, Astrid
    Croes, Lieselot
    Delombaerde, Danielle
    Szabados, Bernadett
    Powles, Thomas
    PHARMACEUTICALS, 2023, 16 (03)
  • [47] Safety Analysis of Co-Administration of Radiation Therapy with Enfortumab Vedotin Based Regimens in Metastatic Urothelial Carcinoma
    Seyedin, S. N.
    Harada, G. K.
    Garemanian, E.
    Rafizadeh, D.
    Kaakour, D.
    Dwabe, S.
    Rezazadeh, A.
    Daneshvar, M.
    Mar, N.
    CLINICAL GENITOURINARY CANCER, 2024, 22 (06)
  • [48] Mechanistic Insights into the Successful Development of Combination Therapy of Enfortumab Vedotin and Pembrolizumab for the Treatment of Locally Advanced or Metastatic Urothelial Cancer
    Taylor, Caroline
    Patterson, Kamai M.
    Friedman, Devira
    Bacot, Silvia M.
    Feldman, Gerald M.
    Wang, Tao
    CANCERS, 2024, 16 (17)
  • [49] Enfortumab vedotin 202: Phase 2 study of enfortumab vedotin for previously treated advanced solid tumors, including breast cancer
    Ono, Makiko
    Bruce, Justine Yang
    Feinstein, Trevor
    Muro, Kei
    Derleth, Christina
    Gorla, Seema
    Wu, Chunzhang
    Novik, Yelena
    CANCER RESEARCH, 2022, 82 (04)
  • [50] Enfortumab Vedotin With or Without Pembrolizumab in Cisplatin-Ineligible Patients With Previously Untreated Locally Advanced or Metastatic Urothelial Cancer
    O'Donnell, Peter H.
    Milowsky, Matthew I.
    Petrylak, Daniel P.
    Hoimes, Christopher J.
    Flaig, Thomas W.
    Mar, Nataliya
    Moon, Helen H.
    Friedlander, Terence W.
    McKay, Rana R.
    Bilen, Mehmet A.
    Srinivas, Sandy
    Burgess, Earle F.
    Ramamurthy, Chethan
    George, Saby
    Geynisman, Daniel M.
    Bracarda, Sergio
    Borchiellini, Delphine
    Geoffrois, Lionnel
    Rey, Jose Pablo Maroto
    Ferrario, Christiano
    Carret, Anne-Sophie
    Yu, Yao
    Guseva, Maria
    Moreno, Blanca Homet
    Rosenberg, Jonathan E.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (25) : 4107 - +
12345